Neutralizing Anti-Rituximab Antibodies and Relapse in Membranous Nephropathy Treated With Rituximab
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Neutralizing Anti-Rituximab Antibodies and Relapse in Membranous Nephropathy Treated With Rituximab
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-01-13
DOI
10.3389/fimmu.2019.03069
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Presence of anti-rituximab antibodies predicts infusion-related reactions in patients with systemic lupus erythematosus
- (2019) Chris Wincup et al. ANNALS OF THE RHEUMATIC DISEASES
- Rituximab bioavailability in primary membranous nephropathy
- (2019) Sonia Boyer-Suavet et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- High-Dose Rituximab and Early Remission in PLA2R1-Related Membranous Nephropathy
- (2019) Barbara Seitz-Polski et al. Clinical Journal of the American Society of Nephrology
- Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy
- (2019) Fernando C. Fervenza et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunization to rituximab is more frequent in systemic autoimmune diseases than in rheumatoid arthritis: ofatumumab as alternative therapy
- (2019) Alice Combier et al. RHEUMATOLOGY
- Detection and quantification of rituximab in the human urine
- (2017) Roland Jacobs et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Phospholipase A2 Receptor 1 Epitope Spreading at Baseline Predicts Reduced Likelihood of Remission of Membranous Nephropathy
- (2017) Barbara Seitz-Polski et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Safety of Rituximab Compared with Steroids and Cyclophosphamide for Idiopathic Membranous Nephropathy
- (2017) Jan A.J.G. van den Brand et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Rituximab in multiple sclerosis: Frequency and clinical relevance of anti-drug antibodies
- (2017) Nicky Dunn et al. Multiple Sclerosis Journal
- Lipid-Reduction Variability and Antidrug-Antibody Formation with Bococizumab
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Randomised controlled trial comparing ofatumumab to rituximab in children with steroid-dependent and calcineurin inhibitor-dependent idiopathic nephrotic syndrome: study protocol
- (2017) Pietro Ravani et al. BMJ Open
- Rituximab in multiple sclerosis: Frequency and clinical relevance of anti-drug antibodies
- (2017) Nicky Dunn et al. Multiple Sclerosis Journal
- Rituximab for Severe Membranous Nephropathy: A 6-Month Trial with Extended Follow-Up
- (2016) Karine Dahan et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Immunogenicity to Biotherapeutics – The Role of Anti-drug Immune Complexes
- (2016) Murli Krishna et al. Frontiers in Immunology
- Immunogenicity of Biotherapy Used in Psoriasis: The Science Behind the Scenes
- (2015) Denis Jullien et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Anti-Phospholipase A2 Receptor Antibody Titer Predicts Post-Rituximab Outcome of Membranous Nephropathy
- (2015) P. Ruggenenti et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Epitope Spreading of Autoantibody Response to PLA2R Associates with Poor Prognosis in Membranous Nephropathy
- (2015) B. Seitz-Polski et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- B Cell Reconstitution after Rituximab Treatment in Idiopathic Nephrotic Syndrome
- (2015) M. Colucci et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Genetic homogeneity but IgG subclass–dependent clinical variability of alloimmune membranous nephropathy with anti-neutral endopeptidase antibodies
- (2015) Marina Vivarelli et al. KIDNEY INTERNATIONAL
- Clinical relevance of immunogenicity of biologics in psoriasis: Implications for treatment strategies
- (2014) J.-M. Carrascosa et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Rituximab versus Azathioprine for Maintenance in ANCA-Associated Vasculitis
- (2014) Loïc Guillevin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Thrombospondin Type-1 Domain-Containing 7A in Idiopathic Membranous Nephropathy
- (2014) Nicola M. Tomas et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy
- (2013) Durga Kanigicherla et al. KIDNEY INTERNATIONAL
- The immunogenicity of anti-TNF therapy in immune-mediated inflammatory diseases: a systematic review of the literature with a meta-analysis
- (2012) Sandra Garcês et al. ANNALS OF THE RHEUMATIC DISEASES
- Interindividual Variability of Response to Rituximab: From Biological Origins to Individualized Therapies
- (2011) G. Cartron et al. CLINICAL CANCER RESEARCH
- Rituximab-Induced Depletion of Anti-PLA2R Autoantibodies Predicts Response in Membranous Nephropathy
- (2011) L. H. Beck et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- New Anti-CD20 Monoclonal Antibodies for the Treatment of B-Cell Lymphoid Malignancies
- (2010) Tadeusz Robak et al. BIODRUGS
- Rituximab Therapy in Idiopathic Membranous Nephropathy: A 2-Year Study
- (2010) F. C. Fervenza et al. Clinical Journal of the American Society of Nephrology
- Dealing with immunogenicity of biologicals: assessment and clinical relevance
- (2010) Gerrit J Wolbink et al. CURRENT OPINION IN RHEUMATOLOGY
- Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis
- (2010) Rachel B. Jones et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of rituximab on physical function and quality of life in patients with rheumatoid arthritis previously untreated with methotrexate
- (2010) William Rigby et al. ARTHRITIS CARE & RESEARCH
- Clinical response, pharmacokinetics, development of human anti-chimaeric antibodies, and synovial tissue response to rituximab treatment in patients with rheumatoid arthritis
- (2009) R M Thurlings et al. ANNALS OF THE RHEUMATIC DISEASES
- Immunogenicity of rituximab in patients with severe pemphigus
- (2009) Enno Schmidt et al. CLINICAL IMMUNOLOGY
- Rituximab Treatment of Adult Patients with Steroid-Resistant Focal Segmental Glomerulosclerosis
- (2009) G. Fernandez-Fresnedo et al. Clinical Journal of the American Society of Nephrology
- Anti-CD20 monoclonal antibodies: historical and future perspectives
- (2009) S. H. Lim et al. HAEMATOLOGICA
- M-Type Phospholipase A2Receptor as Target Antigen in Idiopathic Membranous Nephropathy
- (2009) Laurence H. Beck et al. NEW ENGLAND JOURNAL OF MEDICINE
- Variability in the biological response to anti-CD20 B cell depletion in systemic lupus erythaematosus
- (2008) D Albert et al. ANNALS OF THE RHEUMATIC DISEASES
- Rituximab treatment of idiopathic membranous nephropathy
- (2007) F.C. Fervenza et al. KIDNEY INTERNATIONAL
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now